1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Ayman Saad: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant Avatrombopag - Platelet Disorder | Phase 2 | Withdrawn | Ayman Saad | 2022-12-01 | 2021-12-09 |
avatrombopag (1)